BAX vs. SOLV: Baxter vs. Solventum Stock Comparison
How do Baxter (BAX) and Solventum (SOLV) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
Baxter (BAX) and Solventum (SOLV) both belong to the Health Care Equipment & Supplies industry, though BAX is classified under Health Care Equipment while SOLV falls under Health Care Supplies.
Baxter (BAX) carries decades of public-market history since October 27, 1981, while Solventum (SOLV) listed on March 26, 2024 — long-window comparisons have far more historical data on the BAX side.
| Profile Item | BAX | SOLV |
|---|---|---|
| Name | Baxter International Inc. | Solventum Corporation |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry Group | Health Care Equipment & Services | Health Care Equipment & Services |
| GICS Industry | Health Care Equipment & Supplies | Health Care Equipment & Supplies |
| GICS Sub-Industry | Health Care Equipment | Health Care Supplies |
| Market Capitalization | 13.34 billion USD | 15.36 billion USD |
| Currency | USD | USD |
| Exchange | NYSE | NYSE |
| Listing Date | October 27, 1981 | March 26, 2024 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | BAX | SOLV |
|---|---|---|
| Total Return (1Y) | 45.72% | 25.89% |
| Total Return (3Y, Annualized) | -5.53% | -- |
| Total Return (5Y, Annualized) | -17.96% | -- |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | BAX | SOLV |
|---|---|---|
| Volatility (1Y, Annualized) | 42.31% | 30.06% |
| Beta (5Y) | 0.62 | 0.62 |
| Max Drawdown (5Y) | -80.61% | -39.98% |
| Avg. Volume (3M) | 6.53M | 1.05M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | BAX | SOLV |
|---|---|---|
| Sharpe Ratio (1Y) | 0.98 | 0.72 |
| Sortino Ratio (1Y) | 1.42 | 1.08 |
Profitability
ROE (TTM)
Baxter (BAX) reports a negative ROE of -9.04%; negative ROE can reflect losses or negative shareholders’ equity, so it is harder to read as capital efficiency. Meanwhile Solventum (SOLV) reports 3.19%, ranking against industry peers normally.
BAX
Health Care Equipment & Services industry group
-9.04%
- Max
- 47.61%
- Q3
- 14.36%
- Median
- 5.45%
- BAX
- -9.04%
- Q1
- -10.67%
- Min
- -47.01%
SOLV
Health Care Equipment & Services industry group
3.19%
- Max
- 47.61%
- Q3
- 14.36%
- Median
- 5.45%
- SOLV
- 3.19%
- Q1
- -10.67%
- Min
- -47.01%
Net Margin (TTM)
Baxter (BAX) reports a negative net margin of -6.23%, usually indicating a net loss over the period. Meanwhile Solventum (SOLV) reports 1.91%, ranking against industry peers normally.
BAX
Health Care Equipment & Services industry group
-6.23%
- Max
- 29.35%
- Q3
- 9.33%
- Median
- 2.18%
- BAX
- -6.23%
- Q1
- -6.29%
- Min
- -28.46%
SOLV
Health Care Equipment & Services industry group
1.91%
- Max
- 29.35%
- Q3
- 9.33%
- Median
- 2.18%
- SOLV
- 1.91%
- Q1
- -6.29%
- Min
- -28.46%
Operating Margin (TTM)
Both Baxter (BAX) at 9.88% and Solventum (SOLV) at 6.82% run core operations about as efficiently as their industries’ norm — neither stands out on operating profitability.
BAX
Health Care Equipment & Services industry group
9.88%
- Max
- 35.43%
- Q3
- 14.14%
- BAX
- 9.88%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
SOLV
Health Care Equipment & Services industry group
6.82%
- Max
- 35.43%
- Q3
- 14.14%
- SOLV
- 6.82%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
Profitability Metrics
| Metric | BAX | SOLV |
|---|---|---|
| ROE (TTM) | -9.04% | 3.19% |
| ROA (TTM) | 2.71% | 2.29% |
| Net Margin (TTM) | -6.23% | 1.91% |
| Operating Margin (TTM) | 9.88% | 6.82% |
| Gross Margin (TTM) | 33.37% | 55.13% |
Growth
Revenue Growth
Baxter (BAX) at 5.72% is around its peer norm for revenue growth, while Solventum (SOLV) at 0.86% drops into the bottom quartile, signaling weaker demand or pricing momentum.
EPS Growth
Only one side can be read here: Solventum (SOLV) reports EPS growth of 221.74%, ranked against its industry; Baxter (BAX) has no EPS growth figure this period.
Growth Metrics
| Metric | BAX | SOLV |
|---|---|---|
| Revenue Growth (YoY) | 5.72% | 0.86% |
| Revenue Growth (3Y CAGR) | 3.79% | 0.79% |
| EPS Growth (YoY) | -- | 221.74% |
| EPS Growth (3Y CAGR) | -- | 4.51% |
Financial Strength
Current Ratio (MRQ)
Baxter (BAX) at 1.79 keeps current ratio within its industry’s typical mid-range, while Solventum (SOLV) at 1.03 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for SOLV.
BAX
Health Care Equipment & Services industry group
1.79
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- BAX
- 1.79
- Q1
- 1.37
- Min
- 0.30
SOLV
Health Care Equipment & Services industry group
1.03
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- SOLV
- 1.03
- Min
- 0.30
Debt / Equity (MRQ)
Both Baxter (BAX) at 1.36 and Solventum (SOLV) at 1.10 lean more heavily on debt funding than most peers, landing in the higher-leverage quartile of their industries.
BAX
Health Care Equipment & Services industry group
1.36
- Max
- 1.88
- BAX
- 1.36
- Q3
- 0.91
- Median
- 0.58
- Q1
- 0.16
- Min
- 0.00
SOLV
Health Care Equipment & Services industry group
1.10
- Max
- 1.88
- SOLV
- 1.10
- Q3
- 0.91
- Median
- 0.58
- Q1
- 0.16
- Min
- 0.00
Financial Strength Metrics
| Metric | BAX | SOLV |
|---|---|---|
| Current Ratio (MRQ) | 1.79 | 1.03 |
| Debt / Equity (MRQ) | 1.36 | 1.10 |
| Net Debt / EBITDA | 3.73 | 4.66 |
Dividends
Dividend Yield (TTM)
Solventum (SOLV) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Baxter (BAX) reports a yield of 0.16%, ranking against industry peers normally.
BAX
Health Care Equipment & Services industry group
0.16%
- BAX
- 0.16%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
SOLV
Health Care Equipment & Services industry group
0.00%
- SOLV
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Baxter (BAX) reports payout ratio above 100% at 154.67%, meaning dividends exceeded current-period earnings; Solventum (SOLV) pays no dividend (payout 0.00%).
BAX
Health Care Equipment & Services industry group
154.67%
- BAX
- 154.67%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
SOLV
Health Care Equipment & Services industry group
0.00%
- SOLV
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | BAX | SOLV |
|---|---|---|
| Dividend Yield (TTM) | 0.16% | 0.00% |
| Dividend Payout Ratio (TTM) | 154.67% | 0.00% |
Valuation
P/E Ratio (TTM)
An earnings multiple is available for just one side: Solventum (SOLV) trades at 101.55 times trailing earnings, ranked against its peers, while Baxter (BAX) has no P/E ratio this period.
BAX
Health Care Equipment & Services industry group
--
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
- BAX
- --
SOLV
Health Care Equipment & Services industry group
101.55
- SOLV
- 101.55
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
P/S Ratio (TTM)
On P/S ratio, both Baxter (BAX) at 1.15 and Solventum (SOLV) at 1.88 are priced roughly in line with their industries — neither looks cheap nor rich on a sales basis.
BAX
Health Care Equipment & Services industry group
1.15
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- BAX
- 1.15
- Q1
- 1.10
- Min
- 0.03
SOLV
Health Care Equipment & Services industry group
1.88
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- SOLV
- 1.88
- Q1
- 1.10
- Min
- 0.03
P/B Ratio (MRQ)
On P/B ratio, both Baxter (BAX) at 2.05 and Solventum (SOLV) at 3.20 are valued close to their industries’ norm against book — neither stands out from peers.
BAX
Health Care Equipment & Services industry group
2.05
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- BAX
- 2.05
- Q1
- 1.73
- Min
- -1.31
SOLV
Health Care Equipment & Services industry group
3.20
- Max
- 11.68
- Q3
- 6.12
- SOLV
- 3.20
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
Valuation Metrics
| Metric | BAX | SOLV |
|---|---|---|
| P/E Ratio (TTM) | -- | 101.55 |
| P/S Ratio (TTM) | 1.15 | 1.88 |
| P/B Ratio (MRQ) | 2.05 | 3.20 |
| Free Cash Flow Yield (TTM) | 9.16% | 1.31% |